Vertex Pharmaceuticals Incorporated
US ˙ NasdaqGS ˙ US92532F1003

SecurityVRTX / Vertex Pharmaceuticals Incorporated
InstitutionDestination Wealth Management
Latest Disclosed Ownership1,552 shares
Latest Disclosed Value $ 693,030
Destination Wealth Management reports 0.91% increase in ownership of VRTX / Vertex Pharmaceuticals Incorporated

On May 15, 2026 - Destination Wealth Management filed a 13F-HR form disclosing ownership of 1,552 shares of Vertex Pharmaceuticals Incorporated (US:VRTX) valued at $693,030 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 1,538 shares of Vertex Pharmaceuticals Incorporated. This represents a change in shares of 0.91% during the quarter. The current value of the position is $664,784 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,552 14 0.91 693 -0.57 0.0180
2026-02-13 2025-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 1,538 -104 -6.33 697 8.40 0.0182
2025-11-14 2025-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,642 89 5.73 643 -6.95 0.0177
2025-08-14 2025-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 1,553 -1,724 -52.61 691 -56.49 0.0203
2025-05-15 2025-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,277 -252 -7.14 1,589 11.75 0.0501
2025-02-07 2024-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,529 168 5.00 1,421 -9.09 0.0444
2024-11-25 2024-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,361 144 4.48 1,563 3.72 0.0485
2024-07-25 2024-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,217 17 0.53 1,508 12.72 0.0498
2024-05-14 2024-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,200 3 0.09 1,338 2.85 0.0445
2024-02-14 2023-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,197 107 3.46 1,301 21.04 0.0451
2023-11-14 2023-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,090 -2 -0.06 1,075 -1.29 0.0418
2023-08-11 2023-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,092 0 0.00 1,088 11.70 0.0406
2023-05-05 2023-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,092 -100 -3.13 974 5.75 0.0369
2023-02-13 2022-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,192 100 3.23 922 2.91 0.0367
2022-11-14 2022-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,092 0 0.00 895 2.76 0.0376
2022-07-29 2022-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,092 -6 -0.19 871 7.80 0.0351
2022-05-12 2022-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,098 11 0.36 808 19.17 0.0299
2022-02-04 2021-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,087 0 0.00 678 21.07 0.0240
2021-10-25 2021-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,087 -44 -1.41 560 -11.25 0.0217
2021-08-13 2021-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,131 3 0.10 631 -6.10 0.0244
2021-05-05 2021-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,128 7 0.22 672 -8.94 0.0278
2021-02-11 2020-12-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,121 23 0.74 738 -12.46 0.0321
2020-11-12 2020-09-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,098 0 0.00 843 -6.23 0.0427
2020-08-14 2020-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 3,098 -347 -10.07 899 9.63 0.0486
2020-05-13 2020-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 3,445 3,445 820 0.0503
2019-07-19 2019-06-30 13F VERTEX PHARMACEUTICALS COM 92532F100 0 -17 -100.00 0 -100.00
2019-05-01 2019-03-31 13F VERTEX PHARMACEUTICALS COM 92532F100 17 17 3 0.0002
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.